PrEP
-
Whitman-Walker Launches HIV Vaccination Study in D.C.
Whitman-Walker is excited to announce our participation in MOSAICO, a new HIV vaccine research study.
Read More » -
High Cost Repels D.C. College Students from HIV Drug
Black college students in D.C. cite the high cost of PReP, a drug used to prevent HIV, for why they…
Read More » -
D.C. Launches Campaign to Promote HIV Pill
D.C.'s Department of Health has launched a campaign to educate the city's transgender community about the importance of taking a…
Read More » -
HIV Preventive Drug Absent in Black Communities
Currently the only approved PrEP medicine is a drug called Truvada. Though it has been available since 2014, statistics from…
Read More » -
D.C. Uses Controversial Ad for HIV Prevention Pill
A bold new advertisement campaign launched by the D.C. Department of Health uses sexual innuendos to promote the use of…
Read More » -
Men Who Took Daily Pill Stayed HIV-Free, Kaiser Permanente Says
(NBC News) – Men who took a once-a-day pill to prevent HIV infection were completely protected for months and sometimes…
Read More » -
Truvada – a preventive drug against HIV and AIDS
[TECHSONIA] Truvada is a drug that functions against HIV. It was approved in the early 2000s. It lowers virus production…
Read More »
